Skip to Content
Worthington & Caron, PC Worthington & Caron, PC
Mesothelioma Empowerment
Top

Our Mission

  • Medical Empowerment

    Get the information you need to make informed decisions about your treatment.

  • Legal Empowerment

    Get the compensation you need to address the financial cost of your illness.

  • Going For The Gold

    Helping empower our clients with over $2.5 Billion in recoveries. We fight for our clients!

  • Giving Back To The Community

    Unprecedented Support for Mesothelioma Research. See how we can help!

Tazemetostat (Tazverik®)
|

Tazemetostat Proves Effective in Treatment of Mesothelioma with BAP1 Mutation

Tazemetostat (Tazverik®)

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have published promising results of a phase 2 clinical trial for patients with pleural mesothelioma found to have a BAP1 genetic mutation.

According to the researchers, the BAP1 mutation is found in over 50% of patients with pleural mesothelioma.

Researchers administered Tazemetostat (Tazverik®) orally to 74 patients whose mesothelioma was found to contain the BAP1 mutation and had previously undergone chemotherapy. The drug was administered in 21-day cycles for approximately 17 cycles. After a median follow-up of 35.9 weeks, the disease control rate in part 2 was 54% at week 12.

The phase 2 trial was led by MSK oncologist Marjorie Zauderer, “This is the first targeted therapy we’ve seen to have a real effect on slowing or stopping pleural mesothelioma,” Dr. Zauderer says. “After we found out how common BAP1 was in mesothelioma, I took action to make sure every mesothelioma case at MSK was tested for the mutation.”

The study was published May 16, 2022, in the journal Lancet Oncology.

Get Empowered

We put your medical and personal needs first and provide compassionate representation.
  • Please enter your first name.
  • Please enter your last name.
  • Please enter your phone number.
    This isn't a valid phone number.
  • Please enter your email address.
    This isn't a valid email address.
  • Please make a selection.
  • Please enter a message.
  • By submitting, you agree to receive text messages from Worthington & Caron, PC at the number provided, including those related to your inquiry, follow-ups, and review requests, via automated technology. Consent is not a condition of purchase. Msg & data rates may apply. Msg frequency may vary. Reply STOP to cancel or HELP for assistance. Acceptable Use Policy